TAN vs. CURE
TAN (Invesco Solar ETF) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both exchange-traded funds - TAN is a Alternative Energy Equities fund tracking the MAC Global Solar Energy Index, while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, TAN returned 12.35%/yr vs 14.03%/yr for CURE. At a 0.38 correlation, their price movements are largely independent. TAN charges 0.69%/yr vs 1.08%/yr for CURE.
Performance
TAN vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TAN achieves a 19.22% return, which is significantly higher than CURE's -10.45% return. Over the past 10 years, TAN has underperformed CURE with an annualized return of 12.35%, while CURE has yielded a comparatively higher 14.03% annualized return.
TAN
- 1D
- -4.17%
- 1M
- -11.21%
- YTD
- 19.22%
- 6M
- 16.19%
- 1Y
- 82.66%
- 3Y*
- -4.69%
- 5Y*
- -7.06%
- 10Y*
- 12.35%
CURE
- 1D
- 3.78%
- 1M
- 4.14%
- YTD
- -10.45%
- 6M
- -10.93%
- 1Y
- 35.07%
- 3Y*
- 1.46%
- 5Y*
- 0.46%
- 10Y*
- 14.03%
TAN vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TAN Invesco Solar ETF | 19.22% | 48.31% | -37.61% | -26.79% | -5.24% | -25.10% | 233.96% | 66.53% | -25.67% | 54.38% |
CURE Direxion Daily Healthcare Bull 3x Shares | -10.45% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between TAN and CURE is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.38 |
Over the past year, the correlation between TAN and CURE has dropped to 0.15 - well below their long-term average of 0.38, suggesting their price drivers have been diverging.
TAN vs. CURE - Sectors Allocation Comparison
Sectors
TAN
CURE
Technology
-
Energy
-
Utilities
-
Financial Services
-
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Healthcare
-
Real Estate
-
-
Technology
TAN
CURE
-
Energy
TAN
CURE
-
Utilities
TAN
CURE
-
Financial Services
TAN
CURE
-
Industrials
TAN
CURE
-
Basic Materials
TAN
-
CURE
-
Communication Services
TAN
-
CURE
-
Consumer Cyclical
TAN
-
CURE
-
Consumer Defensive
TAN
-
CURE
-
Healthcare
TAN
-
CURE
Real Estate
TAN
-
CURE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TAN vs. CURE — Risk / Return Rank
TAN
CURE
TAN vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Solar ETF (TAN) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TAN | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.37 | ||
| Sortino ratioReturn per unit of downside risk | +1.38 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.16 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 3.97 | 1.13 | +2.84 |
| Martin ratioReturn relative to average drawdown | 12.49 | 2.51 | +9.97 |
Loading charts...
Drawdowns
TAN vs. CURE - Drawdown Comparison
The maximum TAN drawdown since its inception was -95.29%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for TAN and CURE.
Loading charts...
Drawdown Indicators
| TAN | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.29% | -69.19% | -26.10% |
Max Drawdown (1Y)Largest decline over 1 year | -20.94% | -31.10% | +10.16% |
Max Drawdown (3Y)Largest decline over 3 years | -64.40% | -51.93% | -12.47% |
Max Drawdown (5Y)Largest decline over 5 years | -73.95% | -52.23% | -21.72% |
Max Drawdown (10Y)Largest decline over 10 years | -78.53% | -69.19% | -9.34% |
Current DrawdownCurrent decline from peak | -73.11% | -28.92% | -44.19% |
Average DrawdownAverage peak-to-trough decline | -78.47% | -18.18% | -60.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.64% | 13.98% | -7.34% |
Volatility
TAN vs. CURE - Volatility Comparison
Invesco Solar ETF (TAN) has a higher volatility of 16.60% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 15.41%. This indicates that TAN's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TAN | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.60% | 15.41% | +1.19% |
Volatility (6M)Calculated over the trailing 6-month period | 28.78% | 31.09% | -2.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.50% | 44.49% | -5.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.14% | 43.92% | -3.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.16% | 49.58% | -11.42% |
TAN vs. CURE - Expense Ratio Comparison
TAN has a 0.69% expense ratio, which is lower than CURE's 1.08% expense ratio.
Dividends
TAN vs. CURE - Dividend Comparison
TAN has not paid dividends to shareholders, while CURE's dividend yield for the trailing twelve months is around 1.19%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.19% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
TAN Invesco Solar ETF | 0.00% | 0.00% | 0.50% | 0.09% | 0.00% | 0.00% | 0.09% | 0.30% | 0.69% | 1.77% | 5.04% | 1.60% |
Frequently Asked Questions
TAN and CURE have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TAN has higher volatility (16.60%) compared to CURE (15.41%). In terms of maximum drawdown, TAN dropped -95.29% vs CURE's -69.19%.
On 10-year performance, CURE leads with 14.03% vs 12.35% for TAN. On fees, TAN is cheaper at 0.69% per year. On volatility, CURE has been the lower-risk option at 15.41%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 14.03% return vs 12.35%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
TAN is cheaper with a 0.69% expense ratio, compared with 1.08% for CURE.
CURE has the higher dividend yield at 1.19%, compared with 0.00% for TAN.
TAN is categorized as Alternative Energy Equities, while CURE is Leveraged Equities. TAN tracks MAC Global Solar Energy Index, while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: Invesco and Direxion. Their fees differ too: 0.69% for TAN and 1.08% for CURE.
TAN currently has the higher Sharpe Ratio (2.16 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TAN and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer